Effect of loganin on experimental diabetic nephropathy

Phytomedicine

Volumn 19, Issue 3-4, 2012, Pages 217-222

  Jiang, Wang Lin ^a,b   Zhang, Shu Ping ^a   Hou, Jian ^b   Zhu, Hai Bo ^b  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b State Key Laboratory of Long acting and Targeting Drug Delivery Technologies   (China)

Author keywords

Connective tissue growth factor; Diabetic nephropathy; Loganin

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GLUCOSE; LOGANIN; MITOGEN ACTIVATED PROTEIN KINASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EPITHELIUM CELL; EXPERIMENTAL STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; CELL LINE; CELL PROLIFERATION; CONNECTIVE TISSUE GROWTH FACTOR; CORNUS; CYSTATIN C; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; IRIDOIDS; KIDNEY; MALE; MAP KINASE SIGNALING SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT GAIN;

CORNUS OFFICINALIS;

EID: 84857041142     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.08.064     Document Type: Article

References (31)

1. W.N. Abdel, and R.M. Mason Connective tissue growth factor and renal diseases: some answers, more questions Curr. Opin. Nephrol. Hypertens. 13 2004 53 58 (Pubitemid 39069899)
2. F.K. Ahmad, Z. He, and G.L. King Molecular targets of diabetic cardiovascular complications Curr. Drug Targets 6 2005 487 494 (Pubitemid 40916273)
3. P. Boor, K. Sebeková, T. Ostendorf, and J. Floege Treatment targets in renal fibrosis Nephrol. Dial. Transplant. 22 2007 3391 3407 (Pubitemid 350212482)
4. D. Borkemeyer, A. Sorokin, and M.J. Dunn Multiple intracellular MAP kinase signaling cascade Kidney Int. 49 1996 1187 1198 (Pubitemid 26166398)
5. L. Cai, W. Li, G. Wang, L. Guo, Y. Jiang, and Y.J. Kang Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway Diabetes 51 2002 1938 1948 (Pubitemid 34564309)
6. L.D. Dworkin Serum cystatin C as a marker of glomerular filtration rate Curr. Opin. Nephrol. Hypertens. 10 2001 551 553 (Pubitemid 32783801)
7. M. Fricker, P. Wiesli, M. Brändle, B. Schwegler, and C. Schmid Impact of thyroid dysfunction on serum cystatin C Kidney Int. 63 2003 1944 1947 (Pubitemid 36513345)
8. X. Gao, J. Li, H. Huang, and X. Li Connective tissue growth factor stimulates renal cortical myofibroblast-like cell proliferation and matrix protein production Wound Repair Regen. 16 2008 408 415 (Pubitemid 351661579)
9. R. Goldschmeding, J. Aten, Y. Ito, I. Blom, T. Rabelink, and J.J. Weening Connective tissue growth factor: just another factor in renal fibrosis? Nephrol. Dial. Transplant. 15 2000 296 299 (Pubitemid 30116458)
10. R.E. Gilbert, L.L. Wu, D.K. Kelly, A.J. Cox, J. Wilkinson-Berka, C.I. Johnston, and M.E. Cooper Pathological expression of renin and angiotensin II in renal tubule following subtotal nephrectomy: Implications for the pathogenesis of tubulointerstitial fibrosis Am. J. Pathol. 155 1998 429 440 (Pubitemid 29370393)
11. D. Jay, H. Hitomi, and K.K. Griendling Oxidative stress and diabetic cardiovascular complications Free Radic. Biol. Med. 40 2006 183 192 (Pubitemid 43069343)
12. T. Kobayashi, H. Okada, T. Inoue, Y. Kanno, and H. Suzuki Tubular expression of connective tissue growth factor correlates with interstitial fibrosis in type 2 diabetic nephropathy Nephrol. Dial. Transplant. 21 2006 548 549 (Pubitemid 43160023)
13. H.B. Lee, and H. Ha Plasminogen activator inhibitor-1 and diabetic nephropathy Nephrology 10 2005 S11 S13
14. K.Y. Lee, S.H. Sung, S.H. Kim, Y.P. Jang, T.H. Oh, and Y.C. Kim Cognitive-enhancing activity of loganin isolated from Cornus officinalis in scopolamine-induced amnesic mice Arch. Pharm. Res. 32 2009 677 683
15. S.M. Mauer Structural-functional correlations of diabetic nephropathy Kidney Int. 45 1994 612 622 (Pubitemid 24065101)
16. M. Nakamura, T. Ozaki, A. Ishii, M. Konishi, Y. Tsubota, T. Furui, H. Tsuda, I. Mori, K. Ota, and K. Kakudo Calcitonin induces connective tissue growth factor through ERK1/2 signaling in renal tubular cells Exp. Mol. Med. 41 2009 307 315
17. Y. Nawa, J. Endo, and T. Ohta The inhibitory effect of the components of Cornus officinalis on melanogenesis J. Cosmet. Sci. 58 2007 505 517
18. P. Paueksakon, M.P. Revelo, L.J. Ma, C. Marcantoni, and A.B. Fogo Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy Kidney Int. 61 2002 2142 2148 (Pubitemid 34539331)
19. L. Raij, S. Azar, W. Keane, and G.Z. Zhang Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats Kidney Int. 26 1984 137 143 (Pubitemid 14017051)
20. G. Remuzzi, and T. Bertani Pathophysiology of progressive nephropathies N. Engl. J. Med. 339 1998 1448 1456 (Pubitemid 28516069)
21. N. Sakai, T. Wada, K. Furuichi, Y. Iwata, K. Yoshimoto, K. Kitagawa, S. Kokubo, M. Kobayashi, A. Hara, J. Yamahana, T. Okumura, K. Takasawa, S. Takeda, M. Yoshimura, H. Kida, and H. Yokoyama Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy Am. J. Kidney Dis. 45 2005 54 65 (Pubitemid 40038045)
22. R. Sarközi, B. Miller, V. Pollack, E. Feifel, G. Mayer, A. Sorokin, and H. Schramek ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells J. Cell. Physiol. 211 2007 88 100 (Pubitemid 46363898)
23. O. Schück, V. Teplan, J. Sibová, and M. Stollová Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment Int. J. Clin. Pharmacol. Ther. 42 2004 93 97 (Pubitemid 38219920)
24. K.M. Schmidt-Ott Unraveling the role of connective tissue growth factor in diabetic nephropathy Kidney Int. 73 2008 375 376 (Pubitemid 351186281)
25. F.A. Van Nieuwenhoven, L.J. Jensen, A. Flyvbjerg, and R. Goldschmeding Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? Nephrol. Dial. Transplant. 20 2005 6 10 (Pubitemid 40207600)
26. N.A. Wahab, N. Yevdokimova, B.S. Weston, T. Roberts, X.J. Li, H. Brinkman, and R.M. Mason Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy J. Biochem. 359 Pt 1 2001 77 87 (Pubitemid 32939209)
27. G. Wolf, and F.N. Ziyadeh Molecular mechanisms of diabetic renal hypertrophy Kidney Int. 56 1999 393 405 (Pubitemid 29353136)
28. H. Xu, J. Shen, H. Liu, Y. Shi, L. Li, and M. Wei Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress Can. J. Physiol. Pharmacol. 84 2006 1267 1273 (Pubitemid 46707375)
29. S. Yamagishi, and T. Imaizumi Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy Curr. Pharm. Des. 11 2005 2279 2299 (Pubitemid 40872698)
30. L.Q. Yuan, Y. Lu, X.H. Luo, H. Xie, X.P. Wu, and E.Y. Liao Taurine promotes connective tissue growth factor (CTGF) expression in osteoblasts through the ERK signal pathway Amino Acids 32 2007 425 430 (Pubitemid 46559573)
31. G. Zhou, C. Li, and L. Cai Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway Am. J. Pathol. 165 2004 2033 2043 (Pubitemid 39578381)